Unregulated supply of medicines compromises quality assurance and risks patient safety. The
emergence of illegal medicines trafficking in Morocco presents a major health threat, which highlights
the need for region-wide alignment in policies to drive stringent regulatory enforcement and robust
health systems that ensure population- wide access to safe medicines. Herein, we draw on insights
from a situational analysis in Morocco, as a lower- middle income setting, to present access to
medicines through regulated supply procedures as a vital prerequisite for quality assurance and
patient safety.